TEMPLATE-FIXED PEPTIDOMIMETICS AS MEDICAMENTS AGAINST HIV AND CANCER

Details for Australian Patent Application No. 2003232254 (hide)

Owner POLYPHOR AG

Inventors ROBINSON, John, Anthony; ROMAGNOLI, Barbara; ZUMBRUNN, Jurg; DEMARCO, J., Steven; LOCIURO, Sergio; VRIJBLOED, Jan, Wim; GOMBERT, Frank; MUKHERJEE, Reshmi; MOEHLE, Kerstin; OBRECHT, Daniel

Pub. Number AU-A-2003232254

PCT Number PCT/EP03/04641

PCT Pub. Number WO2004/096838

Filing date 2 May 2003

Wipo publication date 23 November 2004

International Classifications

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 014/00 Peptides having more than 20 amino acids

Event Publications

28 August 2003 Complete Application Filed

23 December 2004 Application Open to Public Inspection

  Published as AU-A-2003232254

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name POLYPHOR AG, Application No. 2003232254, under INID (71) correct the name to read POLYPHOR AG; UNIVERSIT#T Z#RICH

19 January 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003232255-NOVEL NUCLEIC ACID SEQUENCES AND PROTEINS OF TUMORS AND NEOPLASIAS OF THE THYROID GLAND

2003232253-TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY